Caleres (CAL) Q1 2026 earnings review
Margin Recovery Initiated, But Divergence Between Segments is Extreme
Caleres delivered a solid start to its 'build-back year,' with Q1 adjusted EPS of $0.38 beating the high end of guidance. Total revenue reversed its prior-year slump to grow 8.5% YoY, heavily aided by the Stuart Weitzman acquisition. However, the real story is the massive divergence in segment profitability. The Brand Portfolio executed a masterclass in margin recovery—expanding gross margins by 520 basis points as tariff mitigation efforts paid off. Conversely, Famous Footwear struggled against a soft consumer backdrop, suffering negative comps and slipping into an operating loss. Management remains confident, raising the lower end of full-year EPS guidance.
🐂 Bull Case
The core thesis for the 2026 'build-back year' was structural margin improvement. With Brand Portfolio gross margins up 520 basis points, management has proven their tariff mitigation and pricing strategies are working.
Stuart Weitzman exceeded expectations, adding $43.9M in top-line revenue and significantly boosting the consolidated gross margin profile (47.3% vs 46.8% ex-SW).
🐻 Bear Case
The company's largest retail segment recorded an operating loss (-$0.4M) as sales declined 2.5% and gross margins compressed 150 basis points, reflecting heavy promotional activity.
Consolidated selling and administrative expenses deleveraged by 70 basis points to 44.1% of sales, primarily driven by $25.6 million in expenses related to the Stuart Weitzman integration.
⚖️ Verdict: 🟢
Bullish. While Famous Footwear's weakness is a legitimate concern, the Brand Portfolio's explosive margin recovery and the successful digestion of Stuart Weitzman provide enough earnings power to confidently support the raised full-year guidance.
Key Themes
Tariff Mitigation Unlocks Massive Profitability
In mid-2025, tariffs were crushing Caleres, directly costing the Brand Portfolio 250 basis points of margin in Q2. Management promised mitigation via factory negotiations and sourcing shifts. Q1 proves this strategy was highly effective: Brand Portfolio gross margin accelerated violently, up 520 basis points YoY to 49.0%. Even excluding Stuart Weitzman, it expanded 140 basis points, confirming the core structural fix.
Famous Footwear's Reversing Profitability
A critical contradiction to the company's upbeat narrative is Famous Footwear. While total company revenue grew, Famous Footwear's sales dropped 2.5% (comps -2.3%). More alarmingly, the segment's operating margin reversed from a healthy 1.5% profit in 25Q1 to a -0.1% loss today. Management points to a 'softer consumer and macroeconomic backdrop,' but the 150 basis point drop in gross margin indicates heavy discounting to clear inventory.
Stuart Weitzman Flips from Drag to Contributor
The Stuart Weitzman acquisition was a major drag on earnings in late 2025 as Caleres liquidated aged inventory and absorbed integration costs. In 26Q1, the brand contributed $24.2M in gross profit. While it still generated an operating loss when factoring in $25.6M in dedicated SG&A, the top-line integration is exceeding expectations, setting up a path to breakeven for the full year.
Lead Brands Defying the Macro Slump
The core organic business remains highly resilient. Stripping out the Stuart Weitzman acquisition, the Brand Portfolio's organic net sales grew 5.8%. Management highlighted 'broad-based growth across channels, both domestically and internationally,' signaling that consumers are still willing to spend on premium lead brands (Sam Edelman, Allen Edmonds) despite cutting back at value chains like Famous Footwear.
Inventory Overhang Requires Monitoring
Total inventory sits at $609.1 million, up $35 million YoY. While management notes that excluding Stuart Weitzman, inventory actually declined by $22.7 million, the sheer volume of new inventory requires flawless execution to clear without further markdown pressure—especially in the sluggish Famous Footwear channel.
Other KPIs
Stable. DTC remains the dominant channel for Caleres, falling slightly from the 70%+ levels seen in late 2025 due to wholesale timing, but structurally higher than historical norms. This shift is a primary driver for the consolidated gross margin lift.
Accelerating. Up a staggering 124% from $17.4 million a year ago. Even excluding Stuart Weitzman, adjusted operating earnings reached $41.0 million. This segment is entirely carrying the company's bottom line right now.
Guidance
Accelerating. Management expects the margin recovery to steepen in Q2 (compared to Q1's +200 bps improvement) as tariff mitigation efforts fully annualize and current tariff rates remain lower.
Accelerating. The bottom end of the range was raised from $1.35. The midpoint of $1.525 represents a massive improvement from FY25's heavily depressed levels, confirming the 'build-back year' thesis.
Decelerating. Things will get worse before they get better for Famous Footwear. Q1 sales were down 2.5%, and the Q2 guide implies a deeper contraction as the consumer backdrop remains soft.
Accelerating. Driven by the inorganic addition of Stuart Weitzman plus 'low-double-digit organic growth', marking a massive acceleration from Q1's 5.8% organic growth.
Key Questions
Famous Footwear Margin Degradation
Famous Footwear's gross margin dropped 150 basis points and slipped into an operating loss. Was this entirely driven by markdowns to clear seasonal inventory, or is there a structural shift in vendor pricing that you are unable to pass on to the consumer?
Stuart Weitzman SG&A Burden
Stuart Weitzman accounted for $25.6M in SG&A this quarter. How much of this is structural ongoing overhead versus one-time integration costs that will fall away in the back half of the year?
Brand Portfolio Organic Acceleration
You are guiding Q2 Brand Portfolio organic sales to grow low-double-digits, an acceleration from Q1's 5.8%. Given the cautious consumer commentary on the Famous Footwear side, what gives you confidence in such strong organic acceleration for the Brand Portfolio?